Cargando…
The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
OBJECTIVES: This study was aimed at providing some insights into the real-life performance of the commercial, clinically validated anti-SARS-CoV-2 antibody assays. METHODS: The residual, anonymized samples from 97 patients referred for anti-SARS-CoV-2 antibodies testing were included in the study. T...
Autores principales: | Swadźba, Jakub, Bednarczyk, Maciej, Anyszek, Tomasz, Kozlowska, Danuta, Panek, Andrzej, Martin, Emilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955809/ https://www.ncbi.nlm.nih.gov/pubmed/33748381 http://dx.doi.org/10.1016/j.plabm.2021.e00212 |
Ejemplares similares
-
Anti-Spike SARS-CoV-2 IgG Assessment with a Commercial Assay during a 4-Month Course after COVID-19 Vaccination
por: Swadźba, Jakub, et al.
Publicado: (2021) -
Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020) -
A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2020) -
Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013) -
Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)